-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Public Health and Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience powered by Apple
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Public Health
- Code of Conduct
- Environmental Social Governance
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions powered by Apple
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBS
Blog
The Future of Pricing Transparency Legislation Promises More Complexity
Jun 04, 2019
The increase in regulatory activity around pricing transparency sends a strong message to the Life Sciences market that manufacturers dismiss at their own risk. Industry participants must adopt proactive strategies to address a wave of new regulations which are designed to limit drug costs by requiring transparency reporting on drug prices and drug price increases. This could be the precursor to more invasive regulatory measures such as government mandated pricing controls. In order to prepare for the additional complexity that is sure to come, manufacturers need a flexible, compliance-based framework that is robust enough to encompass the new regulations that are emerging from states, and scalable enough to accommodate the expectation of eventual Federal involvement in the manner of the CMS’s Open Payments program.
Several states now require some level of price reporting, and there are bills making their way through the legislative process in a number of others — and the only consistent factor is a lack of consistency between their legislative approaches. Some track wholesale acquisition cost (WAC) prices, while some mandate reporting around average manufacturer price (AMP). And a growing number of states have gone beyond these statutorily defined price types, crafting legislation that requires disclosure and reporting of considerably more detailed, granular and even proprietary metrics like product marketing costs, development and input costs.
Each state’s exact reporting requirements and timelines for compliance vary. Just a few examples: In Nevada, reporting of state price transparency and HCP transparency are covered in a single law, creating a dual compliance mandate. Starting this year in California, manufacturers are required to submit notification of price increases 60 days prior to the anticipated change. And in New York, manufacturers of “high spend drugs” are subject to additional requirements — and penalties for noncompliance.
If Federal regulators decide to return to the playbook they used when developing the CMS Open Payments platform, which is likely, that would mean yet another set of different instructions, mandates and procedures for companies to follow.
Although some states have committed to keeping pricing control and transparency data confidential, others have announced their intent to make this information public, just as the Centers for Medicare and Medicaid Open Payments website does at the Federal level. The key difference between spend transparency reporting requirements and price transparency reporting — and the key challenge — is that the marketplace is evolving so that not only government agencies, but competing manufacturers and even consumers could access price transparency reporting data.
Any errors in reporting, even if inadvertent, threaten to expose pharmaceutical companies to regulatory sanctions, penalties and increased oversight. Since drug prices are a sociopolitical issue on an ascendant trajectory, the industry also is vulnerable to public and media scrutiny. Focusing on data integrity and data quality to produce consistent, correct and compliance-focused price transparency reporting can help manufacturers avoid a potential P.R. nightmare.
There is a growing acknowledgement that the legislation in place today is just the tip of the iceberg. Manufacturers today need to proceed with the expectation that these regulatory protocols will only increase and broaden in scale and scope over time. The trajectory of this legislative imperative in the aggregate is very similar to the early stages of spend transparency reporting. As such, it is reasonable to expect the evolution to reflect that of spend transparency reporting, with concurrent activity by states followed by involvement at the federal, and then the global level.
It is still early enough to get out in front of the burgeoning demands around price transparency reporting, but the window to successfully do so is becoming small. Manufacturers need to implement a compliance-focused infrastructure to establish consistent processes and controls.
Being able to identify relevant pricing data across disparate systems is a challenge that needs a comprehensive, compliance-focused strategy. Companies need to commit to investing in this challenge, and work with partners capable of building out efficient processes to make this growing obligation to report price increases more seamless.
For more information about IQVIA Commercial Compliance, please e-mail commercialcompliance@iqvia.com or visit our webpage. Our experts leverage the industry’s leading technologies to deliver streamlined processes and improved efficiencies that solve your toughest engagement and transparency challenges. From automating and managing the entire HCP/O contracting lifecycle, to capturing, collecting, and reporting global spend; to planning efficient and compliant HCP meetings and engagements—discover how our solutions can make compliance easier for you.